Exhibit 5.1
| | |
 | | Cira Centre 2929 Arch Street Philadelphia, PA 19104-2808 +1 215 994 4000 Main +1 215 994 2222 Fax www.dechert.com |
October 12, 2021
FS KKR Capital Corp.
201 Rouse Boulevard
Philadelphia, PA 19112
Re: Registration Statement on Form N-2
Ladies and Gentlemen:
We have acted as counsel to FS KKR Capital Corp., a Maryland corporation (the “Company”), in connection with the preparation and filing of a Registration Statement on Form N-2, filed on October 4, 2021 with the U.S. Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”) (the “Registration Statement”) and the final prospectus supplement, dated October 4, 2021 (including the base prospectus filed therewith, the “Prospectus Supplement”), filed with the Commission on October 6, 2021 pursuant to Rule 424(b)(2) under the Securities Act, relating to the proposed issuance by the Company of $500,000,000 aggregate principal amount of its 1.650% notes due 2024 (the “2024 Notes”), and $750,000,000 aggregate principal amount of its 3.125% notes due 2028 (the “2028 Notes”, and together with the 2024 Notes, the “Notes”), to be sold to the underwriters pursuant to an underwriting agreement substantially in the form filed as Exhibit 1.1 to the Company’s Current Report on Form 8-K filed with the Commission on October 7, 2021 (the “Underwriting Agreement”). This opinion letter is being furnished to the Company in accordance with the requirements of Item 25 of Form N-2 under the Investment Company Act of 1940, as amended, and we express no opinion herein as to any matter other than as to the legality of the Notes.
The 2024 Notes are to be issued pursuant to the indenture dated as of July 14, 2014 (the “Base Indenture”), between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented by the first supplemental indenture dated as of July 14, 2014, by the second supplemental indenture dated as of December 3, 2014, by the third supplemental indenture dated as of April 30, 2015, by the fourth supplemental indenture dated as of July 15, 2019, by the fifth supplemental indenture dated as of November 20, 2019, by the sixth supplemental indenture dated as of April 30, 2020, by the seventh supplemental indenture dated as of December 10, 2020, by the eighth supplemental indenture dated as of June 17, 2021, and the ninth supplemental indenture dated as of October 12, 2021 (the “Ninth Supplemental Indenture,” and together with the Base Indenture, the “2024 Notes Indenture”), between the Company and the Trustee.
The 2028 Notes are to be issued pursuant to the Base Indenture, as supplemented by the first supplemental indenture dated as of July 14, 2014, the second supplemental indenture dated as of December 3, 2014, the third supplemental indenture dated as of April 30, 2015, the fourth supplemental indenture dated as of July 15, 2019, the fifth supplemental indenture dated as of November 20, 2019, the sixth supplemental indenture